Monitoring antibiotic concentrations with rapid Optimer-based diagnostic assays
Novel biosensor diagnostics can improve patient outcomes and reduce healthcare costs.
Download our application note to discover how our partner, QSM Diagnostics, is integrating Optimer technology into its rapid diagnostic platform to revolutionize how we diagnose and treat infections.
This application note demonstrates:
- the excellent selectivity of Optimer reagents developed to the moxifloxacin antibiotic target.
- how Optimers are being incorporated into a rapid biosensor diagnostic platform to detect moxifloxacin across the clinical concentration range.
- maintenance of the performance of the Optimer-based biosensor in a complex human serum matrix.
- how this platform can be adapted to offer rapid diagnostic solutions for a range of biomarkers and disease conditions.
Download application note Read our interview with QSM Diagnostics